AU2014248002A1 - Matrix metalloproteinases and uses thereof - Google Patents
Matrix metalloproteinases and uses thereof Download PDFInfo
- Publication number
- AU2014248002A1 AU2014248002A1 AU2014248002A AU2014248002A AU2014248002A1 AU 2014248002 A1 AU2014248002 A1 AU 2014248002A1 AU 2014248002 A AU2014248002 A AU 2014248002A AU 2014248002 A AU2014248002 A AU 2014248002A AU 2014248002 A1 AU2014248002 A1 AU 2014248002A1
- Authority
- AU
- Australia
- Prior art keywords
- mmp
- mmps
- tissue
- prommps
- inactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/6416—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24017—Stromelysin 1 (3.4.24.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24024—Gelatinase A (3.4.24.24), i.e. matrix metalloproteinase 2 or MMP2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24034—Neutrophil collagenase (3.4.24.34)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24035—Gelatinase B (3.4.24.35), i.e. matrix metalloprotease 9 or MMP9
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24065—Macrophage elastase (3.4.24.65), i.e. metalloelastase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361808861P | 2013-04-05 | 2013-04-05 | |
| US61/808,861 | 2013-04-05 | ||
| PCT/US2014/033009 WO2014165780A2 (en) | 2013-04-05 | 2014-04-04 | Matrix metalloproteinases and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2014248002A1 true AU2014248002A1 (en) | 2015-11-19 |
Family
ID=51659357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014248002A Abandoned AU2014248002A1 (en) | 2013-04-05 | 2014-04-04 | Matrix metalloproteinases and uses thereof |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412916B (zh) * | 2014-09-19 | 2021-04-30 | 达森生物药业有限公司 | 治疗乳腺癌的组合物及其用途 |
| CN105412917B (zh) * | 2014-09-19 | 2021-04-30 | 达森生物药业有限公司 | 治疗实体瘤的抗癌组合物及其用途 |
| CN105477628B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 抗癌组合物及其用途 |
| CN105477627B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 治疗前列腺癌的组合物及其用途 |
| WO2017038473A1 (ja) * | 2015-08-28 | 2017-03-09 | 天野エンザイム株式会社 | エンドトキシン低減サーモリシン |
| CN105907840A (zh) * | 2016-03-29 | 2016-08-31 | 苏州大学 | 单细胞水平检测mmp酶活性的方法 |
| US10137179B2 (en) | 2016-05-18 | 2018-11-27 | Hyalo Technologies, LLC | Composition and method of preparation of protease microparticulate slow release preparation |
| CN108451981B (zh) * | 2018-04-21 | 2019-07-23 | 江西汉氏联合干细胞科技有限公司 | 使用皮肤间充质干细胞治疗系统性硬化症 |
| WO2020132608A1 (en) * | 2018-12-20 | 2020-06-25 | The Steadman Clinic And Steadman Philippon Research Institute | Decellularized tendon matrix methods and uses thereof |
| CN114377150B (zh) * | 2021-12-29 | 2023-10-13 | 中山大学南昌研究院 | 一种mmp酶敏感胎盘微环境和肿瘤微环境靶向载体及其制备方法和应用 |
| CN116549325B (zh) * | 2022-01-27 | 2025-07-29 | 南京大学 | 一种组合物、其制备方法、制剂及应用 |
| CN119530138B (zh) * | 2024-12-05 | 2026-01-30 | 中国肉类食品综合研究中心 | 一种用于工业化细胞解离的多酶制剂及其使用方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5770691A (en) * | 1995-06-05 | 1998-06-23 | Regents Of The University Of Minnesota | Discriminatory substrates for MMP hydrolysis |
| JP4335316B2 (ja) | 1996-09-19 | 2009-09-30 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー |
| US6531154B1 (en) | 1997-06-10 | 2003-03-11 | Brown University Research Foundation | Modulated release from biocompatible polymers |
| US6248587B1 (en) | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
| PT1019111E (pt) | 1998-04-27 | 2002-10-31 | Surmodics Inc | Revestimento que liberta um agente bioactivo |
| US6376742B1 (en) | 1999-02-17 | 2002-04-23 | Richard J. Zdrahala | In vivo tissue engineering with biodegradable polymers |
| WO2000051662A1 (en) | 1999-03-04 | 2000-09-08 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
| KR100392501B1 (ko) | 2000-06-28 | 2003-07-22 | 동국제약 주식회사 | 다중 에멀젼법에 의한 서방출성 미립구의 제조방법 |
| EP1611233B1 (en) * | 2003-04-08 | 2016-01-06 | Yeda Research And Development Co., Ltd. | Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| SE0302559D0 (sv) * | 2003-09-25 | 2003-09-25 | Astrazeneca Ab | Method |
| AU2004280616A1 (en) * | 2003-10-08 | 2005-04-21 | Vet-Stem Inc. | Methods of preparing and using stem cell compositions and kits comprising the same |
| US9598669B2 (en) * | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
| US20100247512A1 (en) * | 2006-03-31 | 2010-09-30 | The Regents Of The University Of Michigan | Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue |
| ES2392729T5 (es) * | 2007-09-19 | 2015-08-28 | Pluristem Ltd. | Células adherentes de tejidos adiposos o de placenta y uso de las mismas en terapia |
| US8222206B2 (en) * | 2008-03-04 | 2012-07-17 | Taiwan Advance Bio-Pharm Inc. | Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H |
| JP5572291B2 (ja) * | 2008-04-07 | 2014-08-13 | 独立行政法人国立長寿医療研究センター | 歯髄及び/又は象牙質形成促進のための薬剤及びその利用 |
| WO2010038610A1 (ja) * | 2008-09-30 | 2010-04-08 | オリエンタル酵母工業株式会社 | 新しい軟骨細胞増殖及び分化誘導剤 |
| JP5905446B2 (ja) * | 2010-03-24 | 2016-04-20 | ライフネット ヘルス | Bmp−4ペプチドおよび使用方法 |
| WO2012027721A2 (en) * | 2010-08-27 | 2012-03-01 | Gilead Biologics, Inc | Antibodies to matrix metalloproteinase 9 |
-
2014
- 2014-04-04 HK HK16109565.8A patent/HK1221405A1/zh unknown
- 2014-04-04 AU AU2014248002A patent/AU2014248002A1/en not_active Abandoned
- 2014-04-04 CA CA2908739A patent/CA2908739A1/en not_active Abandoned
- 2014-04-04 BR BR112015025390A patent/BR112015025390A2/pt not_active Application Discontinuation
- 2014-04-04 JP JP2016506654A patent/JP2016520550A/ja active Pending
- 2014-04-04 CN CN201480030453.7A patent/CN105246500A/zh active Pending
- 2014-04-04 RU RU2015147878A patent/RU2015147878A/ru not_active Application Discontinuation
- 2014-04-04 EP EP14779257.6A patent/EP2981276A4/en not_active Withdrawn
- 2014-04-04 SG SG11201508199QA patent/SG11201508199QA/en unknown
- 2014-04-04 US US14/782,118 patent/US20160053250A1/en not_active Abandoned
- 2014-04-04 KR KR1020157031871A patent/KR20160006694A/ko not_active Withdrawn
- 2014-04-04 WO PCT/US2014/033009 patent/WO2014165780A2/en not_active Ceased
- 2014-04-04 EP EP17191200.9A patent/EP3290047A1/en not_active Withdrawn
- 2014-04-04 MX MX2015014053A patent/MX2015014053A/es unknown
-
2015
- 2015-10-05 PH PH12015502306A patent/PH12015502306A1/en unknown
- 2015-11-05 CR CR20150603A patent/CR20150603A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015025390A2 (pt) | 2017-08-29 |
| MX2015014053A (es) | 2016-04-07 |
| KR20160006694A (ko) | 2016-01-19 |
| PH12015502306A1 (en) | 2016-02-15 |
| CA2908739A1 (en) | 2014-10-09 |
| US20160053250A1 (en) | 2016-02-25 |
| WO2014165780A2 (en) | 2014-10-09 |
| EP2981276A4 (en) | 2017-03-22 |
| WO2014165780A3 (en) | 2014-12-18 |
| RU2015147878A (ru) | 2017-05-10 |
| CR20150603A (es) | 2016-04-04 |
| HK1221405A1 (zh) | 2017-06-02 |
| JP2016520550A (ja) | 2016-07-14 |
| EP3290047A1 (en) | 2018-03-07 |
| CN105246500A (zh) | 2016-01-13 |
| EP2981276A2 (en) | 2016-02-10 |
| SG11201508199QA (en) | 2015-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3290047A1 (en) | Matrix metalloproteinases and uses thereof | |
| El Fahime et al. | In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity | |
| Almalki et al. | Effects of matrix metalloproteinases on the fate of mesenchymal stem cells | |
| Boeuf et al. | Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors | |
| US10035834B2 (en) | Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage | |
| JP6588005B2 (ja) | 軟骨形成を刺激するために使用される医薬組成物 | |
| JP2021105015A (ja) | ナノ粒子組成物、その製剤およびその使用 | |
| JP2021506899A (ja) | ボツリヌス毒素細胞結合ドメインポリペプチドおよび線維症関連障害の処置のための使用方法 | |
| CN104204192A (zh) | 间充质干细胞调理的基质及其产生和使用方法 | |
| EP3568154B1 (en) | Compositions and methods for treating farber disease | |
| AU2018257071B2 (en) | Peptide for inducing regeneration of tissue, and use thereof | |
| JP2001508648A (ja) | 腫瘍壊死因子レセプター放出酵素、酵素を含む組成物、およびその使用方法 | |
| Gruber | Mast cells: accessory cells which potentiate fibrosis | |
| US20010049106A1 (en) | ADAMTS polypeptides, nucleic acids encoding them, and uses thereof | |
| US20100143324A1 (en) | Method for treatment of cancers or inflammatory diseases | |
| EP3080246A2 (en) | Compositions and methods for producing and administering brown adipocytes | |
| US20040071687A1 (en) | Adult stem cell recruitment | |
| US20130005037A1 (en) | Method of treating myocardial injury | |
| US6232088B1 (en) | Treatment and prevention of immune rejection reactions | |
| JP2003529356A (ja) | インテグリン媒介性の細胞−細胞相互作用をモジュレートするための方法及び組成物 | |
| KR102544139B1 (ko) | 피부 경화증의 치료를 위한 매트릭스 금속단백분해효소를 포함하는 자가 유래 세포의 전달 | |
| CN112584845A (zh) | 用于调节髓过氧化物酶(mpo)表达的方法和组合物 | |
| WO2001088131A1 (en) | Regulation of mt1-mmp activity | |
| US12527842B2 (en) | Composition for preventing or treating bone diseases comprising CCR2 | |
| Vangala | Mesenchymal stem cells homing to tumour sites: Cancer biology and therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |